SK Bioscience announced on the 17th that it has discussed ways to strengthen partnerships with the Bill & Melinda Gates Foundation on Covid-19 vaccines including SKY Covione.
CEO Mark Sussman, president of the foundation’s Global Health Program Trevor Mundel, Vice Chairman/Co-CEO of SK Discovery Co Ltd Chey Chang-Won, and CEO of SK Bioscience Ahn Jae-yong (right) attended the discussion conducted by the Gates Foundation in Seattle.
At the same day, the Bill and Melinda Gates Foundation and SK Bioscience decided to further strengthen their partnership and successfully complete the ongoing vaccine development. Previously, with the support of the foundation, SK Bioscience successfully developed a COVID-19 vaccine.
SK Bioscience said, “We plan to continue to expand cooperation to perform the tasks necessary for global health and respond to various diseases and infectious diseases in the future.”